DaVita Inc. (NYSE:DVA) Shares Sold by Jump Financial LLC (2024)

Posted by Defense World Staff on May 28th, 2024

Jump Financial LLC lessened its holdings in shares of DaVita Inc. (NYSE:DVA – Free Report) by 85.8% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 2,284 shares of the company’s stock after selling 13,797 shares during the quarter. Jump Financial LLC’s holdings in DaVita were worth $239,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. State of Michigan Retirement System raised its stake in shares of DaVita by 0.6% during the fourth quarter. State of Michigan Retirement System now owns 15,939 shares of the company’s stock valued at $1,670,000 after purchasing an additional 100 shares in the last quarter. Treasurer of the State of North Carolina lifted its stake in shares of DaVita by 0.5% in the 3rd quarter. Treasurer of the State of North Carolina now owns 24,503 shares of the company’s stock worth $2,316,000 after acquiring an additional 123 shares during the period. PNC Financial Services Group Inc. lifted its stake in shares of DaVita by 1.0% in the 3rd quarter. PNC Financial Services Group Inc. now owns 15,088 shares of the company’s stock worth $1,426,000 after acquiring an additional 153 shares during the period. Daiwa Securities Group Inc. boosted its holdings in shares of DaVita by 3.7% in the fourth quarter. Daiwa Securities Group Inc. now owns 4,802 shares of the company’s stock valued at $503,000 after acquiring an additional 171 shares in the last quarter. Finally, Donoghue Forlines LLC increased its stake in shares of DaVita by 1.4% during the fourth quarter. Donoghue Forlines LLC now owns 13,144 shares of the company’s stock valued at $1,377,000 after acquiring an additional 184 shares during the period. Institutional investors and hedge funds own 90.12% of the company’s stock.

Insider Activity

In related news, Director Barbara J. Desoer sold 5,030 shares of the firm’s stock in a transaction that occurred on Friday, May 10th. The shares were sold at an average price of $138.81, for a total value of $698,214.30. Following the completion of the transaction, the director now owns 10,954 shares of the company’s stock, valued at approximately $1,520,524.74. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 2.00% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. Truist Financial upped their target price on DaVita from $135.00 to $150.00 and gave the stock a “hold” rating in a research report on Wednesday, May 15th. Barclays raised their target price on DaVita from $133.00 to $150.00 and gave the company an “equal weight” rating in a research note on Monday, May 6th. TheStreet upgraded shares of DaVita from a “c+” rating to a “b-” rating in a research report on Wednesday, February 7th. StockNews.com lowered shares of DaVita from a “strong-buy” rating to a “buy” rating in a research report on Monday, May 6th. Finally, UBS Group lifted their price objective on shares of DaVita from $113.00 to $134.00 and gave the stock a “buy” rating in a research note on Wednesday, February 14th. Two research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $144.67.

Check Out Our Latest Stock Analysis on DVA

DaVita Stock Performance

Shares of NYSE DVA opened at $138.54 on Tuesday. DaVita Inc. has a 52-week low of $71.51 and a 52-week high of $145.04. The stock has a market capitalization of $12.15 billion, a price-to-earnings ratio of 15.74, a PEG ratio of 1.06 and a beta of 1.04. The company has a quick ratio of 1.37, a current ratio of 1.43 and a debt-to-equity ratio of 7.95. The stock’s fifty day simple moving average is $135.29 and its 200 day simple moving average is $119.62.

DaVita (NYSE:DVA – Get Free Report) last issued its quarterly earnings results on Thursday, May 2nd. The company reported $2.38 earnings per share for the quarter, topping analysts’ consensus estimates of $1.95 by $0.43. DaVita had a return on equity of 68.52% and a net margin of 6.61%. The firm had revenue of $3.07 billion for the quarter, compared to analysts’ expectations of $3.03 billion. During the same quarter last year, the business posted $1.58 EPS. DaVita’s revenue was up 6.9% on a year-over-year basis. As a group, sell-side analysts forecast that DaVita Inc. will post 9.62 earnings per share for the current fiscal year.

DaVita Profile

(Free Report)

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Featured Stories

Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.

You might be interested in:

WNS Limited Stake Reduced by Vanguard Personalized Indexing Management LLC